Clinical trial
Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia
NCT06330493 is registered in ClinicalTrials.gov with Acotec Scientific Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia
- Lead sponsor
- Acotec Scientific Co., Ltd
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 10, 2025
- Completion date
- August 24, 2026
- Enrollment
- 75 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.